פורמולציה של ארימוקלומול
- 专利权人:
- ORPHAZYME APS
- 发明人:
- 申请号：
- IL25105917
- 公开号：
- IL251059D0
- 申请日:
- 2017.03.09
- 申请国别(地区):
- IL
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL FORMULATION.
- 5- (2-4-DI-HYDROXY-5-ISOPROPIL-PHENYL) -4- (4-MORFOLIN-4-ILME TIL-PHENYL) ISOXAZOL-3-CARBOXYLIC ACID ADDITION SALTS, HYDRATES AND AND FORMULATIONS UNDERSTANDING THESE FORMS.
- ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5-(2,4-DIHYDROXY-5-ISOPROPYL-PHENYL)-4-(4-MORPHOLIN-4-YLMETHYL-PHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE AND FORMULATIONS COMPRISING THESE FORMS
- ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5-(2,4-DIHYDROXY-5-ISOPROPYL-PHENYL)-4-(4-MORPHOLIN-4-YLMETHYL-PHENYL)-ISOXAZOLE-3-CARBOXYLIC ACID ETHYLAMIDE AND FORMULATIONS COMPRISING THESE FORMS
- UNE FORME PHARMACEUTIQUE SOLIDE COMPRENANT DU SOFOSBUVIR
